Condition: Copd · Fatigue · Sponsor: Kirsehir Ahi Evran Universitesi
COPD is an important respiratory system disease that progresses with damage to the airways.Increased mucus secretion and thickening in the airways causes obstruction.This obstruction causes symptoms such as shortness of breath, cough, phlegm and wheezing.The most obvious problem that the emerging symptoms will cause for the patient is fatigue.Coping with fatigue is an important problem in COPD. The main questions it aims to answer are: 1. Does the training given in COPD affect the level of fatigue? 2. Do the education given and text messages sent regarding COPD affect the level of fatigue? In this study, patients were given informative education about COPD and ways to cope with fatigue were explained. Then, in order to increase the permanence of the training, motivational messages and short briefings were continued for 8 weeks.2 messages were sent per week. Three groups were created to reveal the effectiveness of the trainings and messages. Group 1 was trained and messages were sent for 8 weeks. Group 2 was trained and no message was sent. Group 3 is the control group. No training has been provided other than routine maintenance. The initial information of all groups was taken again at the end of the 8th week. Main outcomes: * Dyspnea severity, * COPD general conditions and * Fatigue level. The results obtained will be interpreted by comparing between 3 groups.
This description comes directly from the study's public registry record.
Yasemin CEYHAN · +905464589806 · yasemin-ceyhan@hotmail.com
Always discuss trial participation with your own doctor first.
| Yasemin CEYHAN | Kırşehir, Center, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06286072